| ENVX |
Enovix Corp |
Truong Kristina |
Officer
|
2025-07-01 |
F - D |
2,220 |
10.15 |
22,533.00 |
210,691 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |